Learn More
Description
Includes
Human T-Cell Leukemia
- Concentration: 1.0mg/mL
- Rich in endogenously expressed proteins
- T-Cells were grown to 80-90% confluency
Western blot
Specifications
Specifications
| For Use With (Application) | Western Blot |
| Tissue | T-cell Leukemia |
| Preparation Method | Jurkat (T-cell leukemia) cells, were grown to 80 to 90% confluency, then treated with 1mM pervanadate, a general inhibitor of Protein Tyrosine Phosphatases, for 15 min. at 37°C |
| Quantity | 500 μg |
| Storage Buffer | 1mg/mL in SDS-PAGE Buffer: 62mM Tris pH 6.8, 2% SDS, 0.9% beta-mercaptoethanol, 0.003% Bromophenol Blue, 5% Glycerol |
| Host Species | Human |
| Concentration | 1 mg/mL |
| Content And Storage | -20°C |
Research use only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.